Clinical trial
A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis
NCT02391506 is registered in ClinicalTrials.gov with Cartiva, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis
- Lead sponsor
- Cartiva, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 29, 2015
- Completion date
- March 5, 2019
- Enrollment
- 50 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.